LILLYDIRECT — 2284174
Application number
2284174
Registration number
TMA1405233
Type(s)
Standard Characters
Category
Trademark
CIPO Status
REGISTERED
TM5 status
LIVE/REGISTRATION/Issued
and Active
The trademark application has been registered with the Office.
Filed
2023-09-28
Registered
2026-04-22
Registration Expiry Date
2036-04-22
Registered Owner
ELI LILLY AND COMPANY
LILLY CORPORATE CENTER
INDIANAPOLIS, IN 46285
UNITED STATES OF AMERICA
Agent
BORDEN LADNER GERVAIS LLP
World Exchange Plaza
100 Queen Street, Suite 1300
Ottawa
ONTARIO K1P1J9
Documents
Index headings
- LILLYDIRECT
- LILLY DIRECT
Goods (Nice class & Statement)
- 5
- (1) House mark for a full line of pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone diseases and disorders and musculoskeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, namely, dermatitis, skin pigmentation diseases, eczema, acne, roseacea, ichthyosis, vitiligo, uticaria and alopecia areata, bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, diabetes, dyslipidemia, endocrine diseases and disorders, namely, growth and thyroid disorders, diabetes and obesity, and hormonal diseases, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory pelvic diseases, inflammatory muscle diseases and disorders and pharmaceutical preparations for the treatment of inflammation, namely anti-inflammatory preparations, pharmaceutical preparations for the treatment of kidney diseases and disorders, liver diseases and disorders, lupus, mental health disorders, metabolic diseases and disorders, namely, diabetes, gout, arthritis and anemia, obesity, hyperlipidemia, insulin resistance and metabolic syndrome, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, namely, Alzheimer's, Huntington's disease, cerebral palsy, brain injury, spinal cord injury, and seizure disorders, amyotrophic lateral sclerosis (ALS), encephalitis, meningitis, muscular dystrophy, myasthenia gravis, dystonia, epilepsy, seizures, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases.
- 9
- (2) Downloadable software that allows users to access and receive telemedicine services and that allows telemedicine services providers to perform telemedicine services; downloadable software for telehealth and telemedicine operations, namely, computer software for accessing medical and health information, computer software to monitor pharmaceutical treatment plans, track patient compliance and verify treatment outcomes of prescription medication, software applications for accessing medical and health information, computer software allowing users to consult with a pharmacist in the field of pharmaceuticals and medications; downloadable computer software for prescribing, ordering, filling, managing and providing information regarding prescription usage, dosage and directions for prescription medications; downloadable software for enabling patients to review details about medications and receive automated warnings of potential adverse interactions of medications; downloadable software for enabling patients to request, receive, track shipment of, and manage prescriptions and orders for pharmaceuticals; downloadable software for enabling patients to access general medical, health, and wellness information and advice.
Services (Nice class & Statement)
- 44
- (1) Healthcare services, namely medical care and analysis services in the field of patient treatment; medical services for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone diseases and disorders and musculoskeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, namely, dermatitis, skin pigmentation diseases, eczema, acne, roseacea, ichthyosis, vitiligo, uticaria and alopecia areata, bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, diabetes, dyslipidemia, endocrine diseases and disorders, namely, growth and thyroid disorders, diabetes and obesity, and hormonal diseases, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory pelvic diseases, inflammatory muscle diseases and disorders and pharmaceutical preparations for the treatment of inflammation, namely anti-inflammatory preparations, pharmaceutical preparations for the treatment of kidney diseases and disorders, liver diseases and disorders, lupus, mental health disorders, metabolic diseases and disorders, namely, diabetes, gout, arthritis and anemia, obesity, hyperlipidemia, insulin resistance and metabolic syndrome, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, namely, Alzheimer's, Huntington's disease, cerebral palsy, brain injury, spinal cord injury, and seizure disorders, amyotrophic lateral sclerosis (ALS), encephalitis, meningitis, muscular dystrophy, myasthenia gravis, dystonia, epilepsy, seizures, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases; arranging and providing medical information services relating to pharmaceuticals, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals.
- 44
- (2) Telemedicine services
Action History
| Action | Action date | Due date | Comments |
|---|---|---|---|
| Filed | 2023-09-28 | ||
| Created | 2023-09-28 | ||
| Formalized | 2023-09-28 | ||
| Pre-Assessment Letter Sent | 2023-10-12 | Multiple Reasons | |
| Search Recorded | 2025-06-23 | ||
| Examiner's First Report | 2025-06-23 | 2025-12-23 | |
| Approved | 2025-11-18 | APPROVED BY PROGRAM EX200M1 | |
| Approval Notice Sent | 2025-11-18 | APPROVED BY PROGRAM EX200M1 | |
| Advertised | 2026-02-04 | Vol.73 Issue 3719 | |
| Registration Pending | 2026-04-22 | ||
| Registered | 2026-04-22 | 2036-04-22 | |
| Amendment to Registration | 2026-10-21 | Corrections made to the statement of goods and services pursuant to subsection 41(3) of the Trademarks Act. | |
| Correspondence Created | 2026-10-21 |